P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML

P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML

Bibliographic Details
Main Authors:	M. Kienhöfer, C. Pauli, S. Delaunay, C. Rohde, M. F. Blank, D. Heid, M. Frye, C. Müller-Tidow
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844544.25273.14

Similar Items

PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA
by: D. Zhao, et al.
Published: (2022-06-01)

P490: SNORNA-DERIVED RNAS (SDRNAS) ARE IMPORTANT DRIVERS OF LEUKEMOGENESIS AND LEUKEMIC MAINTENANCE IN AML
by: R. Zinz, et al.
Published: (2022-06-01)

P382: PTK2B MEDIATES TYROSINE KINASE INHIBITOR DRUG RESISTANCE IN AML ASSOCIATED WITH ALTERED MIGRATION AND ADHESION PROPERTIES
by: C. Allert, et al.
Published: (2022-06-01)

414
by: Leow, Choo Ching, et al.
Published: (2024)

P410: LPIN1 REGULATES LIPID HOMEOSTASIS AND MAINTAINS STEM CELL ENRICHED POPULATIONS IN AML
by: K. Huber, et al.
Published: (2022-06-01)

CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome
by: Kevin M. Bloh, et al.
Published: (2017-06-01)

CRISPR/Cas9-Mediated Phage Resistance Is Not Impeded by the DNA Modifications of Phage T4
by: Yaung, Stephanie J., et al.
Published: (2014)

CRISPR/Cas9-mediated phage resistance is not impeded by the DNA modifications of phage T4.
by: Stephanie J Yaung, et al.
Published: (2014-01-01)

Covalent Modification of Bacteriophage T4 DNA Inhibits CRISPR-Cas9
by: Alexandra L. Bryson, et al.
Published: (2015-07-01)

Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells
by: Karen M. Chapman, et al.
Published: (2015-03-01)

P489: THE LONG NON-CODING RNA LINC01547 PROMOTES PROLIFERATION, CLONOGENICITY, AND CELL CYCLE PROGRESSION IN ACUTE MYELOID LEUKEMIA
by: S. M. N. Zimmermann, et al.
Published: (2022-06-01)

Application of the CRISPR/Cas9 system for modification of flower color in Torenia fournieri
by: Masahiro Nishihara, et al.
Published: (2018-12-01)

Genetic modification of the protozoan Eimeria tenella using the CRISPR/Cas9 system
by: Xinming Tang, et al.
Published: (2020-03-01)

Divergent methylation of CRISPR repeats and cas genes in a subtype I-D CRISPR-Cas-system
by: Ingeborg Scholz, et al.
Published: (2019-07-01)

Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
by: Yongping Zhang, et al.
Published: (2023-08-01)

Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
by: Guadalupe Rosario Fajardo-Orduña, et al.
Published: (2021-05-01)

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
by: Yihua Pang, et al.
Published: (2020-08-01)

Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.
by: Qiang Liu, et al.
Published: (2014-01-01)

CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications
by: Nikhil Deep Kolanu
Published: (2024-01-01)

A Current Approach in Animal Breeding: CRISPR/Cas9 Genome Modification System
by: Fatih Bilgi, et al.
Published: (2016-12-01)

Improving lignocellulosic biofuel production by CRISPR/Cas9‐mediated lignin modification in barley
by: Jae Hoon Lee, et al.
Published: (2021-04-01)

Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
by: Irina N. Marinova, et al.
Published: (2021-09-01)

Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR‐Mediated Base Editors
by: Jianan Li, et al.
Published: (2022-10-01)

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
by: Zsolt Sebestyen, et al.
Published: (2024-04-01)

Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage
by: Li-Ting Niu, et al.
Published: (2021-09-01)

RNA-dependent RNA targeting by CRISPR-Cas9
by: Steven C Strutt, et al.
Published: (2018-01-01)

P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
by: J. Xavier-Ferrucio, et al.
Published: (2022-06-01)

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
by: I. Khan, et al.
Published: (2023-08-01)

CRISPR/Cas-based customization of pooled CRISPR libraries.
by: Jiyeon Kweon, et al.
Published: (2018-01-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance
by: May Levin, et al.
Published: (2021-01-01)

Modification of a Chlamydomonas reinhardtii CRISPR/Cas9 transformation protocol for use with widely available electroporation equipment
by: Rudolph V. Park, et al.
Published: (2020-01-01)

Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
by: Friederike Knipping, et al.
Published: (2017-03-01)

CRISPR-Cas-Integrated LAMP
by: Nazente Atçeken, et al.
Published: (2022-11-01)

JIM 414 - Pentaabiran Statistik
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

JIM 414 - Pentaabiran Statistik
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

IPK 414 - Kejuruteraan Getah
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1997)

JIM 414 – Statistical Inferen
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2016)

JIM 414 - Pentaabiran Statistik
by: PPPJJ, Pusat Pengajian Pendidikan Jarak Jauh
Published: (1999)

Scientific opinion on flavouring group evaluation 414 (FGE.414): 2‐hydroxy‐4‐methoxybenzaldehyde
by: EFSA Panel on Food Additives and Flavourings (FAF), et al.
Published: (2021-11-01)